INDP
Indaptus Therapeutics Inc
NASDAQ: INDP · HEALTHCARE · BIOTECHNOLOGY
$2.80
-4.11% today
Updated 2026-04-30
Market cap
$7.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-21.58
Dividend yield
—
52W range
$2 – $20
Volume
0.1M
Indaptus Therapeutics Inc (INDP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $302317.00 | $305533.00 | $367335.00 | $340675.00 | $555434.00 | $602852.00 | $584815.00 | $745903.00 | $701000.00 | $829000.00 | $859000.00 | $854000.00 | $852.00 | $1403.00 | $1781.00 | $1284.00 | $735.00 | — |
| Gross profit | $-302317.00 | $-305533.00 | $-367335.00 | $-340675.00 | $-555434.00 | $-602852.00 | $-584815.00 | $-745903.00 | $-701000.00 | $-829000.00 | $-859000.00 | $-854000.00 | $-852.00 | $-1403.00 | $-1781.00 | $-1284.00 | $-735.00 | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $2.94M | $1.84M | $2.32M | $4.69M | $2.69M | $2.16M | $4.39M | $4.09M | $10.07M | $24.30M | $35.40M | $26.66M | $2.66M | $2.52M | $6.32M | $7.62M | $7.25M | $9.34M |
| SG&A | — | — | — | — | — | — | — | — | — | — | — | $542556.00 | $916694.00 | $5.21M | $8.59M | $8.76M | $8.01M | $10.49M |
| Operating income | $-4.91M | $-3.93M | $-5.34M | $-7.76M | $-5.37M | $-5.17M | $-7.57M | $-7.60M | $-13.85M | $-29.44M | $-43.33M | $-34.95M | $-3.60M | $-7.73M | $-14.91M | $-16.38M | $-15.37M | $-19.83M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-5.06M | $-3.64M | $-5.06M | $-7.24M | $-4.63M | $-4.49M | $-5.11M | $-6.43M | $-13.14M | $-28.61M | $-42.56M | $-46.09M | $-3.60M | $-7.73M | $-14.91M | $-16.38M | $-15.37M | $-19.83M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-5.36M | $-3.94M | $-5.42M | $-7.58M | $-5.18M | $-5.09M | $-5.69M | $-7.18M | $-13.85M | $-29.44M | $-43.42M | $-46.95M | $-3.60M | $-7.73M | $-14.91M | $-16.38M | $-15.37M | — |
| Interest expense | — | — | — | — | — | — | — | — | $16000.00 | $17000.00 | $23000.00 | $15000.00 | $15114.00 | $17722.00 | $588108.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.36M | $-3.94M | $-5.42M | $-7.58M | $-5.18M | $-5.09M | $-5.69M | $-7.18M | $-13.36M | $-28.91M | $-43.54M | $-47.60M | $-3.58M | $-7.71M | $-14.32M | $-15.42M | $-15.02M | $-20.85M |
| Net income growth (YoY) | — | +26.5% | -37.6% | -39.8% | +31.6% | +1.7% | -11.8% | -26.0% | -86.2% | -116.4% | -50.6% | -9.3% | +92.5% | -115.2% | -85.7% | -7.7% | +2.6% | -38.8% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |